Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Duskey

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nanoscale|November 24, 2025
Drug delivery systems for mitochondrial targetingSofia Tagliavini, Mara Filippini, Alessandro Anderlini, et al.
Molecular Pharmaceutics|October 21, 2015
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene DeliveryNicholas J Baumhover, Jason T Duskey, Sanjib Khargharia, et al.
International Journal of Pharmaceutics|September 4, 2019
ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept studyNatalia Oddone, Francesca Pederzoli, Jason T Duskey, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 2, 2020
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidenceJason T Duskey, Ilaria Ottonelli, Federica Da Ros, et al.
Frontiers in Pharmacology|May 20, 2020
Synthesis, Characterization, and <i>In Vitro</i> Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma TreatmentNatalia Oddone, Frank Boury, Emmanuel Garcion, et al.
Pharmaceutics|January 23, 2020
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept StudyGina P Hoyos-Ceballos, Barbara Ruozi, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nanoscale|November 24, 2025
Drug delivery systems for mitochondrial targetingSofia Tagliavini, Mara Filippini, Alessandro Anderlini, et al.
Molecular Pharmaceutics|October 21, 2015
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene DeliveryNicholas J Baumhover, Jason T Duskey, Sanjib Khargharia, et al.
International Journal of Pharmaceutics|September 4, 2019
ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept studyNatalia Oddone, Francesca Pederzoli, Jason T Duskey, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 2, 2020
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidenceJason T Duskey, Ilaria Ottonelli, Federica Da Ros, et al.
Frontiers in Pharmacology|May 20, 2020
Synthesis, Characterization, and <i>In Vitro</i> Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma TreatmentNatalia Oddone, Frank Boury, Emmanuel Garcion, et al.
Pharmaceutics|January 23, 2020
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept StudyGina P Hoyos-Ceballos, Barbara Ruozi, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2025
Corrigendum to 'Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease' J Control Release. 2021 Feb 10;330:587-598Giulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 7, 2021
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.
Pageof 2